CREATE Medicines, WestGene Expand In Vivo CAR Programs
CAMBRIDGE, Mass., U.S., Aug 28, 2026 CREATE Medicines, Inc. announced a strategic research and development collaboration and license agreement...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CAMBRIDGE, Mass., U.S., Aug 28, 2026 CREATE Medicines, Inc. announced a strategic research and development collaboration and license agreement...
RAMAT-GAN, Israel, July 16, 2026 Galmed Pharmaceuticals Ltd. has announced the breakthrough development of a novel lipid nanoparticle (LNP)...
EDINBURGH & LONDON, UK, June 17, 2026 Resolution Therapeutics announced the expansion of its pipeline for inflammatory and fibrotic...
CAMBRIDGE, Mass., May 12, 2026 Mirai Bio unveiled new preclinical data at the American Society of Gene and Cell...
